Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial. (2016)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-15-2883
PubMed Identifier: 27220960
Publication URI: http://europepmc.org/abstract/MED/27220960
Type: Journal Article/Review
Volume: 22
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 19
ISSN: 1078-0432